Secreted matrix metalloproteinase-14 is a predictor for antifibrotic effect of IC-2-engineered mesenchymal stem cell sheets on liver fibrosis in mice.
Regen Ther
; 18: 292-301, 2021 Dec.
Article
em En
| MEDLINE
| ID: mdl-34504910
ALT, alanine aminotransferase; AST, aspartate aminotransferase; BM-MSCs, bone marrow-derived mesenchymal stem cells; C3, complement C3; CCl4, carbon tetrachloride; DMSO, dimethyl sulfoxide; EDTA, ethylenediamine tetra-acetic acid; FACS, Fluorescence-activated cell sorter; FALD, fontan-associated liver disease; GAPDH, Glyceraldehyde 3-phosphate dehydrogenase; HCC, hepatic cellular carcinoma; HLA, human leukocyte antigen; HSCs, hepatic stellate cells; Hepatic cell sheets; IgG, immunoglobulin G; LC, liver cirrhosis; MMP-14, matrix metalloproteinase; MSCs, mesenchymal stem cells; Matrix metalloproteinase-14; Mesenchymal stem cells; Wnt/ß-catenin signal inhibitor; chronic liver injury; hBM-MNCs, human bone marrow mononuclear cells; iPS cells, induced pluripotent stem cells; αSMA, α-smooth muscle actin
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article